DBV Technologies (DBVT) Current Deferred Revenue (2015 - 2018)
DBV Technologies (DBVT) reported Current Deferred Revenue of $5.0 million for Q4 2018, up 51.54% year-over-year from $3.3 million in Q4 2017, and up 51.54% quarter-over-quarter from $3.3 million in Q4 2017.
DBV Technologies (DBVT) Current Deferred Revenue (2015 - 2018) Analysis & Trends
DBV Technologies (DBVT) has 4 years of Current Deferred Revenue data on file, last reported at $5.0 million in Q4 2018.
- Current Deferred Revenue for Q4 2018 came in at $5.0 million, up 51.54% year-over-year; the trailing twelve-month figure through Dec 2018 was $5.0 million (up 51.54% YoY), and the FY2018 annual result was $5.0 million, up 51.54% from the prior year.
- Current Deferred Revenue grew to $5.0 million in Q4 2018 per DBVT's latest filing, from $3.3 million in the prior quarter.
- Over five years, Current Deferred Revenue peaked at $5.0 million in Q4 2018 and troughed at $867028.8 in Q4 2015.
- A 4-year average of $3.2 million and a median of $3.4 million in 2016 frame the typical range for Current Deferred Revenue.
- The sharpest annual moves came in 2016 and 2017: Current Deferred Revenue jumped 304.48% in 2016, then slipped 6.36% in 2017.
- A 4-year view of Current Deferred Revenue shows it stood at $867028.8 in 2015, then jumped by 304.48% to $3.5 million in 2016, then declined by 6.36% to $3.3 million in 2017, then surged by 51.54% to $5.0 million in 2018.
- Business Quant data shows DBVT's Current Deferred Revenue at $5.0 million in Q4 2018, $3.3 million in Q4 2017, and $3.5 million in Q4 2016.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | DBV Technologies | 6.63 Bn | 6.41 Bn | -3.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 4.98 Mn |
| Dec 31, 2017 | 3.28 Mn |
| Dec 31, 2016 | 3.51 Mn |
| Dec 31, 2015 | 867,028.77 |